134 related articles for article (PubMed ID: 32665121)
21. Interferon inducible antiviral MxA is inversely associated with prostate cancer and regulates cell cycle, invasion and Docetaxel induced apoptosis.
Brown SG; Knowell AE; Hunt A; Patel D; Bhosle S; Chaudhary J
Prostate; 2015 Feb; 75(3):266-79. PubMed ID: 25327819
[TBL] [Abstract][Full Text] [Related]
22. Hypoxia induced upregulation of miR-301a/b contributes to increased cell autophagy and viability of prostate cancer cells by targeting NDRG2.
Guo YJ; Liu JX; Guan YW
Eur Rev Med Pharmacol Sci; 2016; 20(1):101-8. PubMed ID: 26813459
[TBL] [Abstract][Full Text] [Related]
23. TERF1 downregulation promotes the migration and invasion of the PC3 prostate cancer cell line as a target of miR‑155.
Chen W; He LN; Liang Y; Zeng X; Wu CP; Su MQ; Cheng Y; Liu JH
Mol Med Rep; 2020 Dec; 22(6):5209-5218. PubMed ID: 33174061
[TBL] [Abstract][Full Text] [Related]
24. Assessment of the anticancer mechanism of ferulic acid via cell cycle and apoptotic pathways in human prostate cancer cell lines.
Eroğlu C; Seçme M; Bağcı G; Dodurga Y
Tumour Biol; 2015 Dec; 36(12):9437-46. PubMed ID: 26124008
[TBL] [Abstract][Full Text] [Related]
25. The Effects of NDRG2 Overexpression on Cell Proliferation and Invasiveness of SW48 Colorectal Cancer Cell Line.
Golestan A; Mojtahedi Z; Ghalamfarsa G; Hamidinia M; Takhshid MA
Iran J Med Sci; 2015 Sep; 40(5):430-9. PubMed ID: 26379350
[TBL] [Abstract][Full Text] [Related]
26. Long noncoding RNA GAS5 modulates α-Solanine-induced radiosensitivity by negatively regulating miR-18a in human prostate cancer cells.
Yang J; Hao T; Sun J; Wei P; Zhang H
Biomed Pharmacother; 2019 Apr; 112():108656. PubMed ID: 30970507
[TBL] [Abstract][Full Text] [Related]
27. Hypoxia-Responsive Mir-301a and Mir-301b Promote Radioresistance of Prostate Cancer Cells via Downregulating NDRG2.
Wang W; Liu M; Guan Y; Wu Q
Med Sci Monit; 2016 Jun; 22():2126-32. PubMed ID: 27327120
[TBL] [Abstract][Full Text] [Related]
28. Overexpression of SLC6A1 associates with drug resistance and poor prognosis in prostate cancer.
Chen C; Cai Z; Zhuo Y; Xi M; Lin Z; Jiang F; Liu Z; Wan Y; Zheng Y; Li J; Zhou X; Zhu J; Zhong W
BMC Cancer; 2020 Apr; 20(1):289. PubMed ID: 32252682
[TBL] [Abstract][Full Text] [Related]
29. Regulation of apoptosis by a prostate-specific and prostate cancer-associated noncoding gene, PCGEM1.
Fu X; Ravindranath L; Tran N; Petrovics G; Srivastava S
DNA Cell Biol; 2006 Mar; 25(3):135-41. PubMed ID: 16569192
[TBL] [Abstract][Full Text] [Related]
30. Emerging role of N-myc downstream-regulated gene 2 (NDRG2) in cancer.
Hu W; Fan C; Jiang P; Ma Z; Yan X; Di S; Jiang S; Li T; Cheng Y; Yang Y
Oncotarget; 2016 Jan; 7(1):209-23. PubMed ID: 26506239
[TBL] [Abstract][Full Text] [Related]
31. NDRG2 suppresses proliferation, migration, invasion and epithelial-mesenchymal transition of esophageal cancer cells through regulating the AKT/XIAP signaling pathway.
Yang CL; Zheng XL; Ye K; Ge H; Sun YN; Lu YF; Fan QX
Int J Biochem Cell Biol; 2018 Jun; 99():43-51. PubMed ID: 29530788
[TBL] [Abstract][Full Text] [Related]
32. N-myc downstream regulated gene 2 overexpression reduces matrix metalloproteinase-2 and -9 activities and cell invasion of A549 lung cancer cell line in vitro.
Faraji SN; Mojtahedi Z; Ghalamfarsa G; Takhshid MA
Iran J Basic Med Sci; 2015 Aug; 18(8):773-9. PubMed ID: 26557966
[TBL] [Abstract][Full Text] [Related]
33. Midkine silencing enhances the anti-prostate cancer stem cell activity of the flavone apigenin: cooperation on signaling pathways regulated by ERK, p38, PTEN, PARP, and NF-κB.
Erdogan S; Turkekul K; Dibirdik I; Doganlar ZB; Doganlar O; Bilir A
Invest New Drugs; 2020 Apr; 38(2):246-263. PubMed ID: 30993586
[TBL] [Abstract][Full Text] [Related]
34. MiR-483-5p and miR-139-5p promote aggressiveness by targeting N-myc downstream-regulated gene family members in adrenocortical cancer.
Agosta C; Laugier J; Guyon L; Denis J; Bertherat J; Libé R; Boisson B; Sturm N; Feige JJ; Chabre O; Cherradi N
Int J Cancer; 2018 Aug; 143(4):944-957. PubMed ID: 29516499
[TBL] [Abstract][Full Text] [Related]
35. Upregulation of prostate-derived Ets factor by luteolin causes inhibition of cell proliferation and cell invasion in prostate carcinoma cells.
Tsui KH; Chung LC; Feng TH; Chang PL; Juang HH
Int J Cancer; 2012 Jun; 130(12):2812-23. PubMed ID: 21780100
[TBL] [Abstract][Full Text] [Related]
36. Additive naftopidil treatment synergizes docetaxel-induced apoptosis in human prostate cancer cells.
Ishii K; Matsuoka I; Kajiwara S; Sasaki T; Miki M; Kato M; Kanda H; Arima K; Shiraishi T; Sugimura Y
J Cancer Res Clin Oncol; 2018 Jan; 144(1):89-98. PubMed ID: 29098395
[TBL] [Abstract][Full Text] [Related]
37. Overexpression of NDRG2 promotes the therapeutic effect of pazopanib on ovarian cancer.
Cui Y; Shen G; Ma L; Lv Q
J Recept Signal Transduct Res; 2021 Dec; 41(6):546-552. PubMed ID: 33050824
[TBL] [Abstract][Full Text] [Related]
38. NDRG2 acts as a negative regulator downstream of androgen receptor and inhibits the growth of androgen-dependent and castration-resistant prostate cancer.
Yu C; Wu G; Li R; Gao L; Yang F; Zhao Y; Zhang J; Zhang R; Zhang J; Yao L; Yuan J; Li X
Cancer Biol Ther; 2015; 16(2):287-96. PubMed ID: 25756511
[TBL] [Abstract][Full Text] [Related]
39. Protein Disulfide Isomerase 4 Drives Docetaxel Resistance in Prostate Cancer.
Qian S; Zhang S; Wu Y; Ding Y; ; Li X
Chemotherapy; 2020; 65(5-6):125-133. PubMed ID: 33238278
[TBL] [Abstract][Full Text] [Related]
40. Total saponins from Paris forrestii (Takht) H. Li. show the anticancer and RNA expression regulating effects on prostate cancer cells.
Xia C; Chen L; Sun W; Yan R; Xia M; Wang Y; Yang D
Biomed Pharmacother; 2020 Jan; 121():109674. PubMed ID: 31810132
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
